Variable | Distribution |
Median age (range), y | 66.5 (50–83) |
Gender | |
Female | 9 |
Ethnicity | |
White | 13 |
Hispanic/Latino | 2 |
Asian | 2 |
Black | 1 |
Smoking history | |
Never | 8 |
Former | 10 |
Current | 0 |
Supplemental oxygen use | |
Yes | 9 |
Presence of pulmonary fibrosis on imaging | |
Yes | 15 |
Median FVC % predicted (range)* | 59 (38–91) |
Median DLCO % predicted (range)† | 50 (32–79) |
Antigen identified | |
Yes | 9 |
Median distance from ILD clinic (range), miles* | 27.5 (1–100) |
Mean travel time to ILD clinic (SD), minutes* | 82 (38.4) |
Identifies as having a caregiver | |
Yes | 7 |
Comorbidities | |
OSA | 5 |
Pulmonary hypertension | 2 |
Asthma | 2 |
CAD | 3 |
Hypothyroid | 4 |
Depression/anxiety‡ | 2 |
*Data from 16 participants.
†Data from 17 participants.
‡Formal physician diagnosis.
CAD, coronary artery disease; DLCO, Diffusing capacity of the lungs for carbon monoxide ; FVC, forced vital capacity; ILD, interstitial lung disease; OSA, obstructive sleep apnoea; Y, years.